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Purification and functional 
comparison of nine human 
Aquaporins produced in 
Saccharomyces cerevisiae for 
the purpose of biophysical 
characterization
Frederik Bühring Bjørkskov1, Simon Lyngaa Krabbe1, Casper Normann Nurup1, Julie Winkel 
Missel2, Mariana Spulber3, Julie Bomholt3, Karen Molbaek1, Claus Helix-Nielsen3,4,5, Kamil 
Gotfryd2, Pontus Gourdon2,6 & Per Amstrup Pedersen  1
The sparse number of high-resolution human membrane protein structures severely restricts our 
comprehension of molecular physiology and ability to exploit rational drug design. In the search for a 
standardized, cheap and easily handled human membrane protein production platform, we thoroughly 
investigated the capacity of S. cerevisiae to deliver high yields of prime quality human AQPs, focusing 
on poorly characterized members including some previously shown to be difficult to isolate. Exploiting 
GFP labeled forms we comprehensively optimized production and purification procedures resulting in 
satisfactory yields of all nine AQP targets. We applied the obtained knowledge to successfully upscale 
purification of histidine tagged human AQP10 produced in large bioreactors. Glycosylation analysis 
revealed that AQP7 and 12 were O-glycosylated, AQP10 was N-glycosylated while the other AQPs were 
not glycosylated. We furthermore performed functional characterization and found that AQP 2, 6 and 8 
allowed flux of water whereas AQP3, 7, 9, 10, 11 and 12 also facilitated a glycerol flux. In conclusion, our 
S. cerevisiae platform emerges as a powerful tool for isolation of functional, difficult-to-express human 
membrane proteins suitable for biophysical characterization.
For any living organism integral membrane proteins constitute around 30% of the proteome1. This large number 
reflects that a fundamental requirement for life is the capacity of each living cell to maintain homeostasis; a con-
dition that involves a strictly controlled flow of water and water soluble molecules across the plasma membrane 
and organelle membranes. Membrane transport can only be understood in detail if we know the high resolution 
structures of the membrane embedded proteins that mediate the transport. Nevertheless, the number of high res-
olution structures of integral membrane proteins presently amounts to 7122, while currently more than 120,000 
protein structures are deposited in the Protein Data Bank3. These numbers expose how biased our knowledge 
is in relation to protein structures. The lack of structural information not only restricts our understanding of 
cell-biology, but also limits our capacity to implement rational drug design in the search for more target specific 
compounds, as membrane proteins constitute the most prominent class of drug targets4,5.
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The great majority of membrane protein structures originates from prokaryotes and only 59 are of human 
origin2. Experimentally resolved prokaryotic protein structures have therefore been used extensively as models 
for human membrane proteins6. In addition to the uncertainties associated with this approach, modelling is lim-
ited by the fact that around 85% of all human membrane protein families do not have prokaryotic counterparts7. 
Access to more human membrane protein structures is therefore highly desired.
The road to more high resolution structures of human membrane proteins is, however, paved with severe 
obstacles related to difficulties in achieving high-level high quality expression, and establishing efficient purifica-
tion procedures that retain the biological activity of the protein, thereby securing samples suitable for structural 
biology methods such as X-ray crystallography and cryo-EM. Dealing with these issues is far from being trivial 
and usually approached by a laborious trial and error strategy.
The ability to control water homeostasis is essential to all cells and achieved through the action of AQP water 
channels that mediate bidirectional, transmembrane water flow in presence of an osmotic gradient8. AQPs there-
fore play fundamental roles in human physiology9 and AQP malfunctioning is associated with a number of 
human diseases10. The selective water permeability of the AQPs has furthermore demonstrated huge potentials in 
biologically based biomimetic water filtration set ups11.
Thirteen different AQPs have been identified in humans12. These are traditionally subdivided into three major 
groups; the orthodox AQPs; AQP0, AQP1, AQP2, AQP4, AQP5, AQP6 and AQP8; the aquaglyceroporins AQP3, 
AQP7, AQP9 and AQP10 and the super-AQPs, AQP11 and AQP1213. High resolution structures have been 
obtained for four orthodox human AQPs AQP114, AQP215, AQP416 and AQP517 and for AQP0 from cow and 
sheep18. The orthodox AQPs are highly specific for water12 except for AQP6 that also transports nitrate19 and 
AQP8 that is permeable to urea20. The aquaglyceroporins mediate glycerol flux in addition to water and in some 
cases other small molecules like urea21 and arsenic22. A number of small gases like CO223 and NH324, in addition 
to H2O225 and ions26 have also been shown to pass through AQPs. Apart from their capacity to mediate a water 
flux the super-AQPs are less well understood27.
The high-resolution crystal structures of orthodox AQPs from mammals have revealed that these are 
homo-tetramers14,15,17,28,29. Each monomer carries a pore made up of six trans membrane α-helices, five con-
necting loops and two half-helices that penetrate the membrane from opposite sides and assemble into a sev-
enth pseudo transmembrane domain10, Supplementary Figure S1. We have previously successfully produced and 
purified a variety of complex human integral membrane proteins using the S. cerevisiae -based PAP1500 plat-
form30–33. Notably, we have been able to produce human AQP1 to a membrane protein density of 8%31, which is 
extraordinary high. Here we investigated if our expression system is capable of delivering the high yields required 
for biophysical, biochemical, structural or pharmacological studies of other human AQPs, too. We focused our 
study on eight poorly characterized human AQPs 3, 6, 7, 8, 9, 10, 11 and 12, as well as human AQP2 which has 
previously been recognized as difficult to express34,35. A primary structure alignment of the AQPs studied in the 
present paper is shown in Supplementary Figure S2.The molecular weight of each monomer ranges from 27 kDa 
to 37 kDa depending on the AQP (http://www.uniprot.org/).We show high yields of most targets as wells as a 
characterization of their water and glycerol permeabilities.
Results
The expression system. We have previously demonstrated that our S. cerevisiae platform is able to express 
human AQP1 to an exceptional high membrane density31. We therefore investigated whether high level pro-
duction of other human AQPs can also be achieved in our PAP1500 expression system30. This platform includes 
a yeast expression plasmid with two important features; i) the plasmid copy number can be increased from 20 
to approximately 200 per cell prior to induction of recombinant protein production; ii) expression of the het-
erologous protein is controlled by a galactose inducible promoter (Fig. 1) and iii) the PAP1500 host strain that 
concomitantly with recombinant protein production overexpresses the Gal4 transcriptional activator required for 
galactose induced transcription36. Human AQPs 2, 3, 6, 7, 8, 9, 10, 11 and 12 were initially codon optimized for S. 
cerevisiae and produced with a C-terminal TEV-yeGFP-His10 tag suitable for identification of optimal conditions 
for expression and purification. AQP10 was subsequently produced in large scale with only a His8 tag, as well.
AQP accumulation is favored at 15 °C. Previous experience with our expression platform has shown 
that membrane proteins accumulate to a significantly higher membrane density if production is performed at 
15 °C31,32 compared to 30 °C, which is the optimal growth temperature for yeast. To determine if this was also 
true for the nine AQPs analyzed in the present paper we used the fluorescence from the GFP tag to determine 
the kinetics of AQP accumulation in yeast membranes at 15 °C and 30 °C. The data in Fig. 2 show that all proteins 
accumulated to a much higher membrane density at 15 °C compared to 30 °C. In general, at 15 °C each AQP 
accumulated either linearly with time and did not reach at plateau even after 100 hours of induction or reached 
a plateau after approximately 76 hours. In contrast at 30 °C accumulation reached a maximum between 24 and 
48 hours after induction and subsequently leveled off again. The maximal amount of accumulated GFP fluores-
cence was between 2.4 and 44 times lower at 30 °C compared to 15 °C. Figure 2 also reveals that based on GFP 
fluorescence the AQPs constituted between 1% and 8% of the crude membrane protein.
AQPs accumulate as full length proteins in the S. cerevisiae membranes. Data in Fig. 2 showed 
that accumulation of fluorescence in crude yeast membranes were maximal at 15 °C. To determine if the human 
AQPs accumulated as full length proteins in a stable form, crude yeast membranes were separated by SDS-PAGE 
and analyzed by in-gel fluorescence. The results in Fig. 3 demonstrate that all AQPs accumulated in a stable form 
in the yeast membranes as no fluorescent degradation products were visible. It can also be seen that the electro-
phoretic mobility of each AQP matched their molecular weight fairly well. Only exceptions are AQP2 and AQP3 
that showed a slightly higher and lower mobility, respectively, than expected. Aberrant mobility in SDS-PAGE is 
www.nature.com/scientificreports/
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commonly observed for membrane proteins37. It is also evident from Fig. 3 that AQP7 and AQP10 accumulated 
in two different forms that may result from post-translational modifications.
Production temperature dictates the degree of AQP mal-folding. To investigate the temperature 
dependent accumulation demonstrated in Fig. 2, we took advantage of the chemical properties of GFP. It was 
previously shown in E. coli that a C-terminal GFP tag only folds correctly in vivo if its membrane embedded 
fusion partner folds correctly in the plasma membrane38. This folding assay is based on the observations that 
GFP fluorescence is preserved after SDS-PAGE and correctly folded GFP only contributes with 10–15 kDa to the 
molecular weight of its denatured AQP fusion partner. In contrast fully denatured GFP increases the molecular 
weight with 28 kDa. Therefore, only correctly folded GFP can be detected by in-gel fluorescence while both cor-
rectly folded and mal-folded GFP are easily visualized by western blotting due to their rather large difference in 
electrophoretic mobility. As an example we analyzed the AQP2 content in crude membranes by in-gel fluores-
cence and subsequent western blotting with an anti-GFP-antibody. Two important issues are apparent from Fig. 4; 
(i) recombinant AQP2 does accumulate at both temperatures and ii) at 15 °C between 96 and 98% of AQP2-GFP 
fusion was fluorescent and presumably correctly folded while at 30 °C only 10 to 30% was fluorescent and there-
fore probably correctly folded. So folding of AQP2 in the heterologous yeast host seems to be compromised by a 
production temperature of 30 °C.
Recombinant human AQPs localize differently in S. cerevisiae. In human each AQP is expressed 
in a tissue specific manner but also in different cellular compartments39. The intracellular location of some of the 
AQPs is furthermore regulated by post translational modifications39. We applied live cell bioimaging of S. cerevi-
siae producing the individual AQP-TEV-GFP-His10 fusions at 15 °C to discriminate between localization in the 
plasma membrane and in intra-cellular compartments. The data in Fig. 5 show that while AQP12 seems to accu-
mulate primarily in the plasma membrane, AQP2, 6, 7 and 9 only partly accumulated in the plasma membrane 
and AQP3, 8, 10 and 11 localized entirely to internal membranes.
Recombinant human AQP7, 10 and 12 are glycosylated. Bioinformatics predicts that AQP2, 3, 8, 
9 and 10 are N-glycosylated in humans40 and AQP7, 10 and 12 are O-glycosylated41. The predicted glycosyla-
tion sites are shown in Supplementary Figure S3. To clarify if the recombinant AQPs produced in our platform 
are N-glycosylated we used in-gel fluorescence to analyze the electrophoretic mobility of the GFP-His10 tagged 
AQPs before and after treatment with Endo-glycosidase H. It can be seen from Fig. 6 that recombinant AQP10 
Figure 1. Structural map of the expression plasmids used for production of human AQPs in S. cerevisiae. 
Abbreviations used: CG-P, a hybrid promoter carrying the GAL10 upstream activating sequence fused to the 
5′ non-translated leader of the cytochrome-1 gene; AquaporinX, one of the codon optimized human AQPs 2, 
3, 6, 7, 8, 9, 10, 11 or 12; T, a Tobacco Etch Virus (TEV) cleavage site; GFP-His10, yeast enhanced GFP cDNA 
fused to ten histidine codons; 2 μ, a yeast 2 micron origin of replication; leu2-d, a poorly expressed allele of 
the β-iso-propyl-malate dehydrogenase gene; bla, a β-lactamase gene; pMB1, the pMB1origin of replication; 
URA3, the yeast orotidine-5′-phosphate decarboxylase gene. Rapid and efficient construction of all plasmids 
encoding an AQP-TEV-GFP-His10 fusion was carried out by in vivo homologous recombination in S. cerevisiae 
between an AQP-TEV PCR fragment, a TEV-GFP-His10 PCR fragment and the linearized expression plasmid. 
The positions of the three required cross-over events are indicated. Construction of the AQP10-His8 expression 
plasmid was generated in a similar way by transforming with an AQP10-His8 PCR fragment and the linearized 
expression plasmid.
www.nature.com/scientificreports/
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is the only N-glycosylated AQP as the mobility of the slowest migrating very faint AQP10 band was the only one 
affected by Endo-H treatment. From the in-gel fluorescence we estimated that the N-glycosylated band represents 
around 1 percent of the total amount of AQP10. To determine whether AQP7, 10 and 12 are O-glycosylated we 
performed a western blot with Horse Radish Peroxidase conjugated Concanavalin A (ConA) that binds the man-
nose residues found in glycosylated yeast proteins. The data in Fig. 6 show that only the slowest migrating AQP7 
band was recognized by ConA and therefore represents an O-glycosylated version of this AQP while the fastest 
migrating band is not glycosylated as it does not bind ConA. Comparing the in-gel fluorescence and the ConA 
western blot in Fig. 6 shows that ConA specifically recognizes the N-glycosylated version of AQP10. AQP12 was 
also recognized by ConA indicating that this protein accumulates in an O-glycosylated form in our yeast produc-
tion platform.
Recombinant human AQPs show different solubilization profiles. We set up a screen with eight 
different detergents to identify conditions that efficiently solubilize each of the recombinant human AQPs. Based 
on previous experience we performed the screen in presence and absence of cholesteryl-hemi-succinate32,33 at 
three different detergent-protein ratios. Data in Fig. 7 show that solubilization profiles and efficiencies varied sig-
nificantly among the different AQPs. AQP9 stands out as it resisted solubilization in almost all tested detergents, 
as the maximal solubilization amounted to less than thirty percent and was obtained with the zwitter ionic deter-
gents FC-14 and FC-16. For each of the other AQPs we identified several detergents that showed solubilization 
efficiencies of at least 50%. In general the super-AQPs, AQP11 and AQP12, showed the highest solubilization 
Figure 2. Kinetics of AQP-TEV-GFP-His10 accumulation in yeast crude membranes during production at 
either 15 °C or 30 °C. Yeast strains were grown at room temperature until OD450 = 1.0 and cultures were divided 
in two. One portion was transferred to 15 °C ( ) and the other was transferred to 30 °C ( ). After thermo-
equilibration AQP production was initiated by addition of 2% galactose. Crude membranes were isolated from 
cells induced for 0, 28, 52, 76 and 100 hours and fluorescence was determined in 25 µg crude membranes and 
converted to pmol AQP-GFP fusion per mg crude membranes as described in Methods. The pmol/mg was 
subsequently converted to the percentage of crude membranes constituted by each AQP (%). The molecular 
weight of GFP was not included in the latter calculation.
www.nature.com/scientificreports/
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efficiency of all AQPs. This was achieved in the Fos-cholines and LDAO zwitter ionic detergents. The Fos-cholines 
solubilized almost one hundred percent of AQP11 and more that eighty percent of AQP12, while the solubiliza-
tion efficiency for LDAO was around sixty percent. A significant difference between the two super-AQPs is that 
the non-ionic detergents solubilized around fifty percent of AQP11 but less than twenty percent of AQP12. The 
solubilization profiles of AQP2 and AQP6 resemble that of AQP12 as only the zwitter ionic detergents were able 
to solubilize more than 50% of this AQP while the non-ionic detergents solubilized less than 20%. AQPs 3, 7 and 
8 showed more complex solubilization profiles. The highest solubilization efficiencies for all of these AQPs were 
achieved in the zwitter ionic Fos-cholines but some of the non-ionic detergents also solubilized well. DDM for 
example solubilized almost 50% of AQP3 while DM was the most efficient non-ionic detergent for AQP7 and 
AQP8. AQP10 was in a class of its own as the solubilization efficiencies for the non-ionic detergents were in the 
same range as for the zwitter ionic detergents. The detergent screen depicted in Fig. 7 also revealed that irrespec-
tive of the AQP and detergent presence of cholesterol did not significantly affect solubilization efficiencies.
The homogeneity of solubilized AQP is detergent specific and cholesterol dependent. A 
high yield of pure, recombinant AQP requires a detergent that causes efficient solubilization and results in a sta-
ble, homogenous and active AQP preparation. We used fluorescence-detection size exclusion chromatography 
(FSEC) to evaluate the homogeneity of each AQP solubilized in either pure detergent or in a detergent choles-
terol mixture. The FSEC analysis was performed for each detergent that solubilized more that 20 percent of the 
membrane embedded AQP. The FSEC profiles obtained for the orthodox AQPs, the aquaglyceroporins and the 
super-AQPs are shown in Supplementary Figure S4, while the FSEC profiles in detergents used for purification 
of each AQP are shown in Fig. 8. The orthodox AQPs (AQP2, 6 and 8) were most efficiently solubilized by the 
zwitterionic detergents but AQP8 was also solubilized to some extend in the non-ionic detergents (Fig. 7). It 
can be seen from Fig. 8 that the FSEC profile of AQP2 was unaffected by the presence of cholesterol and that the 
mono-dispersity was prominent in all the tested Fos-cholines but FC-14 and FC-16 seem to give the most sym-
metrical elution profiles. The FSEC profiles of AQP6 is seen from Fig. 8 and Supplementary Figure S4 to rely more 
on the detergent used for solubilization, as only FC-16 resulted in a mono-disperse elution profile. The elution 
profile was the same in detergent alone as in detergent with cholesterol. In contrast to the situation with AQP2 
and AQP6 the mono-dispersity of AQP8 was not very good in the zwitter ionic detergent FC-14 and FC-16. In 
fact these detergents seem to interfere strongly with protein-protein interactions as the elution profiles showed 
two peaks indicating partly disassembly of the AQP tetramer. This effect seems to be enhanced by the presence of 
Figure 3. In-gel fluorescence of yeast membrane proteins. Crude membranes isolated from S. cerevisiae 
producing the indicated codon optimized human AQP-TEV-GFP-His10 fusion proteins at 15 °C were separated 
by SDS-PAGE and visualized by in-gel fluorescence. Crude membranes were isolated from yeast harvested at 
the time after induction that showed the highest fluorescence. 25 µg membrane protein was applied to each lane 
of the gel. All samples were separated in the same gel and exposed collectively.
www.nature.com/scientificreports/
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cholesterol. However, the quality of AQP6 solubilized in non-ionic detergents DM, DDM and CY-5 was positively 
affected by the presence of cholesterol during solubilization as presence of CHS gave rise to excellent symmetrical 
elution profiles.
Ni-affinity chromatography results in almost pure AQP preparations. For purification of each 
AQP we selected a detergent that solubilized well and showed a monodisperse FSEC elution profile (Fig. 8). The 
elution profile observed for each AQP during Ni-affinity chromatography is shown in Supplementary Figure S5. 
It is evident from these data that the AQPs show different elution profiles although they all carry the same 
TEV-GFP-His10 tag. To determine the purity of each AQP we separated the peak fractions by SDS-PAGE and 
visualized the AQP content by in-gel fluorescence and subsequently Coomassie staining. The data in Fig. 9 show 
that the protein purity after Ni-affinity chromatography was very high as no or only few non-fluorescent bands 
with minor intensities were visible after Coomassie staining. It is also evident from Fig. 9 that the resistance of the 
tetrameric structure to SDS varies among the nine AQP; for AQPs 7, 8, 10 and 11 the monomer is the only visible 
band while for AQP2, 3, 6, 9 and 12 the dimer, trimer and tetramer are visible, too. AQP6 stands out as the only 
one where the monomer is not the most prominent band after SDS-PAGE.
TEV cleavage releases the AQP to various degrees. Peak fractions from the Ni-affinity purification 
shown in Fig. 9 were treated with TEV protease and subsequently separated by SDS-PAGE along with an undi-
gested sample. The data in Fig. 10 show that except for AQP9 and AQP10 TEV protease digestion was almost 
complete.
Figure 4. Temperature dependent folding of AQP2-TEV-GFP-His10. An AQP2 expressing yeast strain was 
grown at room temperature until OD450 = 1.0 and the culture was divided in two. One portion was transferred 
to 15 °C and the other was transferred to 30 °C. After thermo-equilibration AQP2 production was initiated by 
addition of 2% galactose. Crude membranes were isolated from cells induced for 0, 4, 28, 52, 76 and 100 hours. 
From each time point and both temperatures 25 µg crude membranes were separated by SDS-PAGE and 
AQP2-TEV-GFP-His10 was visualized by in-gel fluorescence. Samples for in-gel fluorescence were separated 
in two SDS-PAGE gels; one for the 15 °C samples the other for the 30 °C samples. The two gels were exposed 
simultaneously to visualize the GFP fluorescence. After fluorescence detection the SDS-PAGE separated 
membrane proteins were blotted onto a PVDF membrane and AQP2-TEV-GFP-His10 was visualized with an 
anti-GFP-antibody. Like for in-gel fluorescence the western blots were imaged simultaneously. CF, correctly 
folded AQP2-TEV-GFP-His10 monomer; MF, mal-folded AQP2-TEV-GFP-His10; %, percent correctly folded 
AQP2-TEV-GFP-His10.
Figure 5. Live cell bio-imaging of yeast cells producing AQP-TEV-GFP-His10 fusions. Yeast cells were grown at 
room temperature in expression medium and induced for recombinant AQP production at 15 °C for 48 hours as 
described in Methods. Pairwise GFP and DIC images are shown.
www.nature.com/scientificreports/
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Purified AQPs are active after reconstitution into polymersomes. Comparison of AQP permeabil-
ities has mostly been based on results obtained in intact cells like Xenopus oocytes42 and yeast cells43. Although 
much valuable information has been gathered the in vivo analysis is complicated by the fact that the recombinant 
AQPs are assumed to be located to the same extent in the plasma membrane. As an approach to circumvent this 
we investigated water and glycerol permeability after reconstitution of purified AQPs into proteopolymersomes 
using stopped flow kinetics. Each AQP was reconstituted into separate proteopolymersomes using the diblock 
copolymer PDMS-PMOXA as previously described44. In short, PDMS-PMOXA self-assembles into polymer-
somes in the absence of protein and into proteopolymersomes in the presence of detergent solubilized mem-
brane protein. We used this method to create a library of separately reconstituted human AQPs, which were 
then extruded through a 200 nm filter. Dynamic light scattering (DLS) was used to measure the hydrodynamic 
diameter of the proteopolymersomes and the blank polymersomes. The proteopolymersomes with human AQPs 
were all measured to be in the range of 110 ± 8 nm to 162 ± 14 nm (Table 1). This is comparable to blank polym-
ersomes which yielded polymersomes with a hydrodynamic diameter of 121 ± 5 nm. This indicates a comparable 
self-assembly process and suggests that the presence of membrane protein did not influence the formation of 
polymersomes and hence that they reconstituted successfully. Since each AQP is reconstituted under the same 
conditions as well as with the same detergent and polymer matrix, we can compare water as well as glycerol trans-
port, and to the best of our knowledge no such comparative study has been described before.
All recombinant human AQPs mediate a water flux. After reconstitution into proteopolymer-
somes we used stopped-flow to measure the separating properties of human AQPs both for water and glycerol. 
Representative data for the normalized light scattering are shown in Supplementary Figure S6 where NaCl was 
used as a draw solute. The light scattering intensity of blank control polymersomes indicates a very slow shrinkage 
and hence very slow water permeability under the applied osmotic pressure. The reconstituted human AQPs show 
a higher light scattering intensity under identical applied osmotic pressure. This indicates a much faster shrinkage 
of the proteopolymersomes and hence a higher water permeability. By fitting the data to a double exponential 
function the faster kinetic rate constant ki (s−1) of the water flux can be determined as the rate constant of AQP 
mediated water transport. This rate constant is directly proportional to the water flux out of the proteopolymer-
somes. The ki-values listed in Table 1 suggest that all the reconstituted AQPs are active and permeable to water. To 
further compare water permeation through the recombinant AQPs we calculated the osmotic water permeability 
of the proteopolymermembrane, Pf, by the following equation45:
=
∗ ∗ Δ
P k
V Osm (1)
f
i
S
V w0
where ki is the experimentally determined kinetic rate constant, S/V0 is the surface to volume ratio, Vw is the par-
tial molar volume of water (0.018 L/mol) and ∆ Osm is the difference in osmolarity between the intra- and extra-
cellular aqueous solutions calculated with the theoretical values for NaCl and PBS buffer. The stopped-flow was 
Figure 6. Human AQP 7, 10 and 12 are glycosylated in yeast. (a) crude membranes from yeast expressing the 
indicated human AQPs were treated with Endo-H over night as described in Methods. Endo-H (+Endo-H) 
and untreated (- Endo-H) samples were separated by SDS-PAGE and analyzed by in-gel fluorescence. The 
samples were separated in the three different gels indicated. Gels were not exposed simultaneously. A red arrow 
indicates a minor fraction of the AQP7 protein with a higher electrophoretic mobility. The blue arrow shows 
the N-glycosylated AQP10 protein band that is sensitive to Endo-H treatment. (b) IMAC purified AQP 7, 10 
and 12 were analyzed by in-gel fluorescence and western blotting using Horse-radish Peroxidase conjugated 
Concanavalin A that binds mannose residues. Arrows indicate AQP proteins that contain mannose residues. 
The gels in “a” have not been cropped while the blot in “b” was cropped to exclude the part of gel containing the 
small molecular weight proteins; the removed part of the blot did not reveal any bands.
www.nature.com/scientificreports/
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performed by mixing equal amounts of NaCl with proteopolymersome-solution giving an osmolarity difference 
of 359.5 mOsm//L across the proteopolymersomes. Since each AQP is stabilized by the same detergent (LDAO) 
and reconstituted by an identical polymer matrix under identical conditions we assume identical 
polymer-to-protein ratios after reconstitution. Hence we can compare the water permeabilities to compare the 
water transport abilities between the AQPs. The calculated Pf values are listed in Table 1 and show a remarkable 
increase in Pf compared to the blank control polymersomes.
AQP3, 7, 9, 10, 11, 12 mediate a glycerol flux. To demonstrate glycerol transport, the proteopolym-
ersomes and blank polymersomes were incubated with glycerol to mediate glycerol transport into the proteo-
polymersomes. This strategy has previously been described45. The hydrodynamic diameter of the polymersomes 
was measured with DLS before and after incubation with glycerol. The difference in diameter (Δdia) before and 
Figure 7. Detergent screen for recombinant human AQPs. AQPs were solubilized as described in Methods 
at the indicated detergent to protein ratios (w/w) (D-P ratio). Solubilization was performed in presence and 
absence of cholesteryl-hemi-succinate. The detergent to cholesteryl-hemi-succinate ratio was three to one 
(w/w). Abbreviations; FC, Fos-Choline; Cymal-5, 5-Cyclohexyl-1-pentyl-β-D-maltoside; DM, n-Decyl-β-
D-maltopyranoside; DDM, n-Dodecyl-β-D-maltopyranoside; LDAO, lauryldimethylamine N-oxide; CHS, 
cholesteryl-hemi-succinate. Solubilization was estimated as GFP fluorescence of the solubilized protein relative 
to the GFP fluorescence in the non-solubilized membranes.
www.nature.com/scientificreports/
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after glycerol incubation is shown in Table 1. Negative values indicate reduction of diameter, while positive values 
indicate increase in diameter. As seen from the data, proteopolymersomes with reconstituted AQP3, 7, 9, 10, 
11 and 12 were swelling. We assign the swelling to permeability of glycerol into the proteoploymersomes. For 
proteopolymersomes with reconstituted AQP2, 6 and 8 we observe small shrinkage which we assign to permea-
bility of water out of the proteopolymersome, due to the difference in osmotic pressure across the polymersome 
membrane.
To further verify activity of the AQPs, we compared stopped-flow measurements of the glycerol incubated 
proteopolymersomes to identical proteopolymersomes without incubation. After overnight incubation with 
glycerol we assumed establishment of an osmolaric equilibrium across the polymer membrane. Exposing the 
proteopolymersomes to a NaCl solution of identical osmolality we could measure water transport across the 
membrane if no glycerol had been transported into the proteopolymersome. The water transport properties were 
evaluated by stopped-flow measurements. Typical measurements of polymersomes and proteopolymersomes are 
shown in Supplementary Figure S7 using NaCl as a draw solute. For reconstituted AQP2, 6, and 8 the ki (s−1) of 
water transport was comparable to that measured before glycerol incubation indicating that there was no uptake 
of glycerol during the incubation time. For reconstituted AQP3, 7, 9, 10, 11 and 12 however the measured ki (s−1) 
was remarkably reduced after incubation with glycerol, indicating that the AQPs were transporting glycerol into 
the proteopolymersomes. The numerical value of the change in ki before and after incubation with glycerol is 
shown in Table 1 as Δki.
Figure 8. Fluorescence-detection size exclusion chromatography of solubilized AQPs. Fluorescence-detection 
size exclusion chromatography was used to evaluate the quality of detergent solubilized AQPs. Detergent 
solubilized membrane proteins were separated on a Superose 6 increase 200 10/300 GL column as described in 
Methods. The figure shows the FSEC profiles for the detergents used for purification and for the same detergents 
supplemented with Cholesteryl hemi-succinate (CHS). All FSEC profiles can be found in the Supplementary 
Figure S4. Fluorescence has been normalized to the peak value in each profile. The void volume is around 8 ml.
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In conclusion, we have shown that all studied AQPs mediate water permeation while all except AQP2, 6 and 8 
also allow a glycerol flux. Our experiments suggest that under identical conditions the water permeation of AQP3 
> AQP9 > AQP12 > AQP8 > AQP2 > AQP10 > AQP11 > AQP6 > AQP7 (Table 1). To our knowledge this is the 
first time that such a large number of AQPs have been analyzed in the same experimental setup.
Large scale production and purification of AQP10-His8. Based on the successful production and 
purification of all human AQPs with preservation of activity, we decided to determine if our platform is useful 
for large-scale production of AQPs. As an example we analyzed expression and purification of non-GFP tagged 
AQP10-His8, in a 15-L bioreactor setup. To identify the optimal time point for cell harvest we analyzed the kinet-
ics of AQP10-His8 accumulation. The data in Fig. 11 reveal that already 48 h post induction, AQP10-His8 was 
visible in crude membranes mainly as intense bands representing monomeric (M) and dimeric (D) forms. As 
evident from the immunoblot, accumulated peaked around 48 hours and then leveled off slowly, indicating the 
existence of a rather large time window for harvesting the cells without compromising the yield. It also appears 
from Fig. 11a that the expression level of AQP10-His8 was approximately the same as for the GFP fusion. For 
large-scale protein purification we used 50 g of cells harvested 95 hours post-induction (Fig. 11b). Based on the 
detergent screen in Fig. 7 crude yeast membranes were solubilized in DM, subjected to IMAC and AQP10-His8 
was eluted in buffer containing bOG to exchange the detergent. Immobilized metal affinity purification (Fig. 11b) 
yielded approximately 26.4 mg of higly pure AQP10-His8 protein (Fig. 11d; lane IMAC C). Subsequent SEC analy-
sis of the IMAC-purified sample revealed that the purified protein was homogenous in bOG and devoid of aggre-
gation (Fig. 11c), as reflected by the monodisperse shape of the main peak and lack of signal in the void volume, 
respectively. Furthermore, the final purity of the SEC-grade sample was high (Fig. 11d; lanes SEC and SEC c). 
In addition we showed that the purified AQP10-His8 protein was able to mediate a water flux and a glycerol flux 
Figure 9. SDS-PAGE of purified AQPs. Based on the elution profile from Supplementary Figure S5, fractions 
containing the highest amount of fluorescence were analyzed by SDS-PAGE. AQP-TEV-GFP-His10 fusions were 
visualized by in-gel fluorescence and the gel was subsequently stained with Coomassie to visualize all proteins 
present in the purified sample. Abbreviations; MW, a molecular weight marker; in-gel, in-gel fluorescence; 
Coom, Coomassie stained gel.
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similar to that of the GFP tagged version after reconstitution into polymersomes (Table 1). It can therefore be 
concluded that our production platform successfully overproduced a high-quality protein sample suitable for 
biophysical studies.
Discussion
The present paper addresses one of the issues that seriously restricts membrane protein characterization; lack of 
access to large amounts of prime quality human membrane proteins. Establishment of a standardized, cheap and 
Figure 10. TEV digestion of purified AQP-TEV-GFP-His10 fusions. The purified AQP-TEV-GFP -His10 fusions 
from Fig. 9 were incubated with TEV protease over night at 4 °C as described in Methods. The outcome of each 
TEV digestion and a non-digested sample were separated by SDS-PAGE and visualized by in-gel fluorescence. 
Abbreviations; MW, molecular weight marker.
AQP Hydrodynamic diameter (nm) ki (s−1) R (%) Pf (10–6 m/s) Δdia (nm) Δki (s−1)
Empty 121 ± 5 200 99.6 624 ± 26 — —
APQ2-GFP 135 ± 8 1784 99.6 6212 ± 83 −17 1
AQP3-GFP 162 ± 14 2111 99.5 8820 ± 773 119 1122
AQP6-GFP 114 ± 4 769 99.7 2261 ± 82 −4 12
AQP7-GFP 110 ± 8 715 99.7 2029 ± 151 2 171
AQP8-GFP 123 ± 13 2065 99.5 6551 ± 701 −8 3
AQP9-GFP 156 ± 14 2052 99.5 8256 ± 751 14 782
AQP10-GFP 115 ± 4 1899 99.7 5624 ± 195 1 121
AQP11-GFP 120 ± 7 844 99.7 2612 ± 156 4 498
AQP12-GFP 135 ± 11 2066 99.5 7194 ± 595 5 1086
AQP10His8 102 ± 15 2056 99.7 5453 ± 742 32 892
Table 1. Activity of purified and reconstituted human AQPs. The second column shows the hydrodynamic 
diameter measured by DLS. Column three shows ki-values as determined by fitting the light scattering signal 
to a second order exponential function. Column four shows the R-value for the fit to the experimental data. 
Column five shows the calculated water permeability (Pf) of each human AQP. Column six shows the change in 
diameter (Δdia) measured by DLS after incubation with glycerol. Column seven shows the change in ki-values 
(Δki) due to incubation with glycerol.
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easily handled platform for high yield recombinant production and purification of human membrane proteins 
would significantly improve our ability to study membrane proteins by means of biochemical and biophysical 
techniques and increase the rate by which membrane protein structures are determined.
The focus of the present paper therefore was to explore how well our Saccharomyces cerevisiae platform30 
matches these requirements. As model proteins we investigated production and purification of nine out of the 
thirteen AQPs found in humans. AQP3, 6, 7, 8, 9, 10, 11 and 12 were selected as no high-resolution structure is 
available for these AQPs. AQP2 was included for reasons of comparison as it has previously been categorized as 
a difficult-to-express protein34,35.
The methylotrophic yeast Picha pastoris has previously been exploited for its capacity to produce all human 
AQPs34,35. A major conclusion from these studies was that although the human AQPs are very homologous, large 
variations were observed in the expression levels. We used the results obtained in P. pastoris to benchmark the 
capacity of our S. cerevisiae platform for AQP production. Out of the nine AQPs analyzed in the present study, 
only AQP3, AQP7, AQP10 and AQP12 were expressed in P. pastoris at a level compatible with purification, while 
AQP2 and AQP8 expression was near the threshold for useful overproduction. AQP6, AQP9 and AQP11 resulted 
in levels below the detection level in P. pastoris. The membrane densities obtained for the various human AQPs 
produced in Pichia amounted to between 0 and 0.7% of the total membrane protein content35. This is in contrast 
to the results presented in the present paper as the nine AQPs accumulated at membrane densities between 0.9% 
and 8% of total membrane protein content (Fig. 2). The major advantage of using P. pastoris as an expression host 
is its ability to grow to an exceptional high cell density resulting in a very large amount of recombinant AQP per 
Figure 11. Large scale expression and purification of AQP10-His8. (a) Accumulation profile for AQP10-His8 
in membranes from S. cerevisiae grown at 15 °C in a computer controlled 15-L bioreactor and induced for 
expression for the indicated periods of time. AQP10-His8 was visualized by Coomassie staining or western 
blotting after SDS-PAGE separation of crude membranes. A membrane sample from AQP10-TEV-GFP-His10 
expressing cells was included as positive control and a membrane sample from empty vector-transformed cells 
was used as a negative control. Arrows indicate monomeric (M, red) and dimeric (D, blue) form of AQP10-
His8, respectively. (b) Immobilized metal affinity chromatography (IMAC) profile of large-scale AQP10-His8 
purification as described in Methods. Briefly, membrane proteins were solubilized in DM and bound protein 
(red line) was competitively eluted by a linear imidazole gradient (50-500 mM; blue line) in 20 mM Tris pH 7.5, 
200 mM NaCl, 20% glycerol, 5 mM β-ME and 1 (w/v)% bOG. (c) Size exclusion chromatography (SEC) elution 
profile of concentrated IMAC-purified sample. SEC was performed using a Superdex increase 200 10/300 GL 
column in 20 mM Tris pH 7.5, 100 mM NaCl, 10% glycerol, 2 mM β-ME and 1% bOG. (d) SDS–PAGE gel 
(Coomassie staining) following large-scale AQP10-His8 purification. IMAC C: concentrated IMAC-purified 
sample, SEC: SEC peak fraction, SEC C: concentrated SEC-purified sample.
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liter. However, for non-secreted proteins like AQPs the amount that can be produced per liter is not as relevant as 
the amount that accumulates per cell. The high density of membrane embedded AQP per cell is more important, 
as this simplifies purification and decreases the associated costs.
Construction of expression plasmids can be one of the most tedious steps in optimizing recombinant protein 
production. To ease the construction of AQP expression plasmids we exploited Saccharomyces cerevisiae’s unique 
ability to perform homologous recombination46. As indicated in Fig. 1 this makes construction of recombinant 
expression plasmids fast, precise and economically feasible as it does not require expensive enzymes but only 
transformation with a linearized expression plasmid and PCR products. Furthermore, this approach generates 
the expression plasmids directly in the yeast host used for expression and does not add any irrelevant nucleotide 
sequences as for instance restriction sites to the final constructs. Presence of such “contaminating” sequences has 
been shown to reduce recombinant protein production47.
As we have seen before for other recombinant membrane proteins31–33 expression temperature was very crit-
ical for obtaining a high yield of AQP. As evident from Fig. 2 all fluorescent AQPs accumulated to a substantially 
higher membrane density at 15 °C compared to 30 °C. Depending on the AQP accumulation at 15 °C was between 
2.4 to 44 times higher than that obtained at 30 °C. So at least in the present platform reduction of the expression 
temperature to 15 °C makes the difference between success and failure in producing active membrane proteins in 
the amounts required for purification.
A potential drawback of using GFP fluorescence to measure recombinant protein accumulation is that flu-
orescence does not necessarily reflect the accumulated amount of full length AQP-TEV-GFP-His10 fusions in 
the cell but may also include fluorescent degradation products. The observation that all AQPs produced at 15 °C 
accumulated with the expected molecular weight and were stable in vivo and during membrane preparation and 
purification demonstrates that degradation was not a problem in the present study (Figs 3 and 9). The measured 
GFP fluorescence in crude membranes therefore originates from accumulation of full length proteins.
To exploit the temperature dependent accumulation we used the C-terminal GFP tag as a folding reporter38. 
The folding assay is based on the observation that correctly folded and fluorescent GFP does not denature during 
SDS-PAGE due to its compact β-barrel structure and therefore only contributes 10–15 kDa to the apparent molec-
ular weight of the AQP38. Non-folded and therefore non-fluorescent GFP, however, contributes around 28 kDa 
to the AQP molecular weight38. The percentage of folded AQP can thus be estimated by western blotting and the 
correctly folded GFP can be identified by in-gel fluorescence and amounted to ≈ 97% at 15 °C and ≈ 20% at 30 °C 
(Fig. 4). As apparent from Fig. 4 reduced accumulation of fluorescent AQP-TEV-GFP-His10 at 30 °C is therefore 
not due to lack of protein production at this temperature but due to inefficient protein folding. Such insufficient 
folding can only be visualized for a C-terminal GFP tagged protein as correctly folded AQP10-His10 cannot be 
distinguished from mal-folded AQP10-His10 by SDS-PAGE. The discrepancy between the optimal growth tem-
perature of yeast which is 30 °C and the optimal temperature for AQP accumulation may be explained by the data 
in Fig. 4 showing that folding of the heterologous AQP2 is strongly favored by the low temperature.
The intracellular localization of AQPs in a number of human tissues is well characterized10 and some AQPs 
including AQP2, AQP7, AQP8, AQP9 and AQP10 shuttle in a regulated way between intracellular compartments 
and the plasma membrane48. In contrast AQP3 always localizes to the plasma membrane while AQP6 and the 
super-AQPs, AQP11 and 12 always accumulate in intracellular compartments48. From Fig. 5 we can see that in S. 
cerevisiae AQP2, 7 and 9 localized partly to the plasma membrane while AQP8 and 10 seem to accumulate exclu-
sively in intracellular compartments. It can also be seen from Fig. 5 that AQP3 seems to localize entirely in intra-
cellular membranes. The intracellular AQPs also show a non-native localization in yeast as substantial amounts 
of AQP6 and AQP12 localized to the plasma membrane while AQP11 does not seem to accumulate in the plasma 
membrane. The observed deviations between AQP localization in yeast and native cells may reflect that the pro-
tein sorting mechanisms in yeast are different from those found in mammalian cells. However, as all nine AQPs 
produced in yeast were functional with respect to transport (Tabel 1 and Supplementary Figure S6), the present 
study shows that activity of a recombinant membrane protein cannot be predicted from its compartmentalization 
in the host cell and localization does not reflect the amount of accumulated AQP, at least not in S. cerevisiae.
Hyper glycosylation is sometimes reported for recombinant proteins produced in S. cerevisiae49. For many pur-
poses, this poses a problem as post-translational modifications introduce heterogeneity to purified recombinant 
proteins and is therefore an important issue for biophysical techniques such as crystallography. Bioinformatics 
predicts that AQP2, 3, 7, 9 and 10 are N-glycosylated40 and AQP7, 10 and 12 are O-glycosylated41 in humans, 
Supplementary Figure S3. In partly agreement with these predictions, SDS-PAGE of crude membranes or puri-
fied AQP7 and AQP10 revealed two bands (Fig. 3). For AQP7 the highest molecular weight was the most intense 
band indicating that the great majority of this protein was post-translationally modified, while for AQP10 the 
most intense band was the fastest migrating band suggesting that only a very minor part of AQP10 was modi-
fied. The heaviest AQP10 band represented an N-glycosylated version as the mobility of this band was sensitive 
to Endo-H treatment (Fig. 6). 35% of recombinant AQP10 produced in P. pastoris was previously shown to be 
N-glycosylated50 so for this protein there seems to be a difference between S. cerevisiae and P. pastoris. In contrast, 
none of the AQP7 bands were affected by Endo-H treatment indicating that this AQP was not N-glycosylated in 
S. cerevisiae. AQP2, AQP3 and AQP9 were also not N-glycosylated as SDS-PAGE separation of crude membranes 
containing these AQPs only showed a single band that was not affected by Endo-H treatment (Fig. 6a). Removal 
of O-glycosylation is more complicated than removal of N-glycosylation51,52. We therefore identified purified 
AQP7, 10 and 12 GFP fusions by in-gel fluorescence and subsequently conducted western blotting using HRP 
conjugated Concanavalin-A. It is apparent from Fig. 6b that the slowest migrating band of AQP7 represents an 
O-glycosylated version and AQP12 was completely O-glycosylated as the single fluorescent AQP12 band was also 
visualized by the Con-A protein. AQP10 did not seem to be O-glycosylated as only the Endo-H sensitive band 
was recognized by Con-A.
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The extent of AQP glycome is far from fully characterized as only AQP1, AQP3 and AQP8 have been shown 
to be N-glycosylated53,54 and O-glycosylation has to our knowledge not been investigated. As the initial step in 
N-and O-glycosylation is preserved among eukaryotes55 we expect that the AQPs glycosylated in our expression 
system will also be glycosylated in native tissue.
Identification of a suitable detergent for purification of a membrane protein in its active form involves screen-
ing as a single detergent that fits all membrane proteins does not exist. This is also emphasized from the detergent 
screen in Fig. 7. Even though the AQPs show a high degree of sequence identity and very likely overall fold they 
respond differently to various detergents. Even among AQPs belonging to the same sub-family we see distinct 
differences. For the orthodox AQP2, 6 and 8, it is interesting that the two former AQPs are only solubilized in the 
zwitter-ionic detergents, while AQP8 is more promiscuous with respect to the detergent and solubilized quite well 
in the milder non-ionic detergents, too. The solubilization profiles among the four aquaglyceroporins also turned 
out to be very different. While AQP9 was almost resistant to solubilization in any of the investigated detergents 
AQP3 and AQP10 solubilized well in zwitter-ionic as well as non-ionic detergents and AQP7 showed a strong 
preference for the zwitter-ionic detergents. There were also significant differences between the two super-AQPs, 
AQP11 and 12. Both AQPs were most efficiently solubilized in the zwitter-ionic detergents but only AQP11 sol-
ubilized quite well in the milder non-ionic detergents, too. It is interesting that supplementation of the detergent 
with cholesterol did not increase the solubilization efficiency in contrast to what we have seen before with other 
membrane proteins produced in the same platform31–33.
The lipid composition differs considerably among different cellular membrane compartments56. It is there-
fore tempting to relate the detergent specific solubilization efficiency to the site of AQP accumulation. AQP2, 
6, 7, 9 and 12 that accumulated partly or exclusively in the plasma membrane (Fig. 5) could only be solubilized 
in the zwitter-ionic detergents while AQP3, 8, 10 and 11 that accumulated exclusively in internal membranes 
(Fig. 5) could also be solubilized in the milder non-ionic detergents. So based upon the nine tested human 
AQPs it appears that intracellular accumulation may be beneficial for solubilization efficiencies in the milder 
non-ionic detergents. Even though we do not know the exact intracellular location of recombinant AQP accu-
mulation, we know that the lipid composition of the membranes that define the Endoplasmic Reticulum and 
the Golgi compartment differs considerable from that of the plasma membrane. The ER membrane displays 
a very low concentration of sterols and complex sphingolipids meaning that this membrane has a more loose 
packing of lipids. The plasma membrane on the other hand is enriched in sphingolipids and sterols that are 
packed at a higher density than in the internal membranes. Consequently, it is tempting to propose that the 
dense lipid packing in the plasma membrane may require more harsh detergents for solubilization of the recom-
binant AQPs.
Even though high solubilization efficiency is very desirable the most important issue is that solubilization 
results in a homogeneous protein preparation. This can be assayed fast and easy by Fluorescence-Detection Size 
Exclusion Chromatography57. To analyze this thoroughly we performed FSEC analysis for each AQP in all deter-
gents giving a solubilization efficiency larger than 20%. Solubilization prior to FSEC analysis was performed both 
in presence and absence of Cholesteryl Hemi-Succinate (Fig. 8 and Supplementary Figure S4). Overall, for each 
AQP we found several detergents that resulted in monodisperse elution profiles. For purification we selected the 
detergent that solubilized with the highest efficiency and showed a monodisperse elution profile.
AQP2 and AQP6 could only be solubilized above 20% in the Fos-choline detergents. All FSEC profiles for 
AQP2 were monodisperse irrespective of the presence or absence of CHS. For AQP6 the profiles were better in 
presence of CHS except for Fos-choline 16 that yielded the same symmetrical monodisperse elution profile in 
detergent and detergent plus CHS. In particular for Fos-choline 12 and 13 monodispersity was greatly improved 
by the presence of CHS. AQP8 differed from the two other orthodox AQP2 and 6 by being soluble in all tested 
detergents, although better in the zwitter-ionic ones. The FSEC profiles in the non-ionic detergents DM, DDM 
and Cy-5 showed very symmetrical FSEC profiles in contrast to FC-14 and FC-16 that resolved as two peaks 
in the chromatogram. This may result from disassembly of the tetrameric structure. Among the aquaglycero-
porins AQP3 and 10 resembled one another as they solubilized well in zwitter-ionic and non-ionic detergents, 
while AQP7 preferred the zwitter-ionic detergents and AQP9 was almost resistant to solubilization. AQP3 yielded 
monodisperse elution profiles in every tested detergent and cholesterol had a positive effect on the elution pro-
file for all detergents. AQP10 generally gave good elution profiles in all detergents except LDAO, FC-13, FC-14 
and FC-16. DM was the detergent giving the most monodisperse profile, while the others and in particular the 
zwitter-ionic detergents resulted in an elution profile with two peaks irrespective of the presence or absence of 
CHS, the only exception being FC-12 alone that also resulted in a monodisperse elution profile. The zwitter-ionic 
detergents were most efficient for solubilization of AQP7. All except FC-12 and FC-16 in absence of CHS gave a 
double peak in the elution profile indicating that the tetrameric AQP structure had disassembled. The non-ionic 
detergents resulted in a more mono-disperse elution profile but with a tendency to yield a shoulder in the profile. 
The AQP9 could only be solubilized in FC-14 and FC-16 and both detergents gave nice elution profiles in the 
FSEC analysis. Presence of CHS improved monodispersity. AQP11 showed a monodisperse elution profile in 
every detergent tested except LDAO and for most detergents CHS improved the elution profile. Only DM seemed 
to have a negative effect on homogeneity as two peaks were observed, and this was prevented by adding CHS 
to the detergent. Decent solubilization of AQP12 was only achieved when using the zwitter-ionic detergents. 
Fortunately, the FSEC profiles in fos-cholines were monodisperse but also DDM gave a monodisperse profile that 
was affected by the presence of CHS.
All nine AQPs were isolated by Ni-affinity chromatography to high purity in the detergent showing the highest 
solubilization efficiency and most monodisperse elution profile. It is evident from Fig. 9 that all proteins were 
reasonably pure after affinity chromatography. The only exception was AQP9 that showed a larger amount of 
contaminating bands; a fact that may reflect the resistance of this AQP to solubilization. It is also evident from 
Fig. 9 that the stability of the detergent solubilized AQP tetramer towards SDS differed among the nine AQP. For 
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AQP2, 3, 8, 9 and 12 the monomer was the most dominant protein but dimers, trimers and tetramers were visible, 
too, while for AQP7, 10 and 11 the monomer was almost exclusively the only visible band. AQP6 was different 
in the sense that the monomeric band was hardly visible while the dimer, trimer and tetramer dominated. So the 
stability of detergent solubilized AQPs as judged by SDS-PAGE appear to vary substantially.
Presence of the GFP tag is a considerable advantage for optimization of expressing and purification. 
Nevertheless, fusion forms may however be disadvantageous for various biophysical characterization techniques 
including crystallography. The TEV site separating each AQP and the GFP-His10 tag was cleavable for most of the 
proteins (Fig. 10). However, the in-gel fluorescence assay revealed that the AQP9 and 10 fusions were not digested 
to completion and also the AQP8 fusion showed a substantial amount of non-digested protein. This is a signifi-
cant problem when dealing with multimeric proteins like the AQPs as presence of a single GFP-His10 tagged mon-
omer causes the entire tetramer to bind the Ni-affinity column thus preventing further purification by reverse 
IMAC. As an alternative we therefore used the information gained from the GFP tagged AQPs to express and 
purify His-tagged AQP10 on a larger scale after growth in a computer controlled 15 liter bioreactor. To address 
the accumulation kinetics of AQP10-His8 in fermenter grown yeast cells we assessed the membranes isolated at 
different time points after induction from the bioreactor using western blotting and Coomassie staining after 
SDS-PAGE (Fig. 11a). In accordance with the shake flask experiments on the GFP-tagged versions (Fig. 2) the 
density of AQP10-His8 peaked at 48 hours after induction and remained at a high but reduced level until 95 hours 
after induction. This indicates that it is relevant to use GFP tagged membrane proteins to optimize production of 
the corresponding histidine tagged version. The solubilized AQP10-His8 fusion could be purified to near homo-
geneity by IMAC (Fig. 11b), and resulted in a monodisperse elution profile after size exclusion chromatography 
(Fig. 11c) at a yield of 26.4 mg AQP10 per 50 g yeast cells (weight weight). The purity of the final product was very 
high as determined by SDS-PAGE (Fig. 11d). It is also promising that the low amount of detergent required for 
AQP10-His8 purification is not in general inhibitory for structural studies.
The purified AQP proteins are only useful for biochemical and biophysical studies if they have preserved their 
ability to mediate transmembrane flow of water and possibly glycerol. It was therefore very encouraging that all 
purified AQPs after reconstitution into polymersomes were able to mediate an osmotically driven water flow and 
that only the aquaglyceroporins and to some extent the super-AQPs were able to confer a transmembrane flux of 
glycerol. All AQPs purified from our production platform were functional and showed the expected activities in 
polymersomes. These data also show that the GFP tag does not prevent the activity of the purified AQPs. Because 
we used the same amount of purified AQP-TEV-GFP-His10 protein for all transport assays we can assume that the 
transport activities reflect the permeability of each AQP. The obtained Pf values allows us to compare the relative 
water permeability of the different AQPs although comparison to Pf values reported in literature is not straight 
forward as these values are dependent on reconstitution system and conditions54.
To our knowledge this is the first time AQP activities have been compared for protein produced in the same 
expression platform and in the same reconstitution and stopped-flow setup. The permeabilities of the super-AQPs 
have for some time been questioned in the literature9,27 but we demonstrate that they both mediate osmotic water 
flow comparable to AQP3 and 6, respectively and also a transmembrane glycerol flux. This is in accordance with 
previous results showing glycerol permeation through AQP1158.
Apart from delivering AQP proteins for the present and future biophysical characterization, the relatively high 
number of AQPs exploited visualizes how general our expression platform is for production of active, high quality 
human membrane proteins. All-in-all the present paper demonstrates that our platform in a cheap and efficient 
manner is convenient for producing complex human membrane proteins like the AQPs in quantities and qualities 
requested for biophysical characterization such as crystallography.
Methods
Yeast strains. Production of recombinant AQPs was carried out in S. cerevisiae strain PAP1500 (α ura3-
52trp1::GAL10-GAL4 lys2-801 leu2Δ1 his3Δ200 pep4::HIS3prb1Δ1.6 R can1 GAL)30.
Plasmid constructions. Codon optimized human AQP cDNAs for S. cerevisiae were purchased from 
Genscript, USA. To C-terminally tag each AQP with a Tobacco Etch Virus cleavage site and a yEGFP-His10 
sequence, we PCR amplified each codon optimized AQP cDNA with the following primers.
 AQP2fv:
 5′ACACAAATACACACACTAAATTACCGGATCAATTCTAAGATAATTATGTGGGAATTGAGATC 
CATA 3′
AQP2rv: 5′AAATTGACTTTGAAAATACAAATTTTCAGCCTTGGTACCTCTAGGTA 3′
 AQP3fv:
 ACACAAATACACACACTAAATTACCGGATCAATTCTAAGATAATTATGGGTAGACAAAAAGA 
ATTAGT
AQP3rv:
5′AAATTGACTTTGAAAATACAAATTTTCAATTTGTTCCTTGTGTTTTACAT 3′
 AQP6fw: 5′ACACAAATACACACACTAAATTACCGGATCAATTCTAAGATAATT ATGGATGCTGTTG 
AACCAGGT 3′
AQP6rv: 5′AAATTGACTTTGAAAATACAAATTTTCTACTGATTCCATTTCGACAGC 3′
 AQP7fw:
 5′ACACAAATACACACACTAAATTACCGGATCAATTCTAAGATAATTATGGTCCAAGCCTCCGG 
TC 3′
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 AQP7rv: 5′AAATTGACTTTGAAAATACAAATTTTCAAATTTTCAAAATGTTCCAAGGCCATAG 
ATTC 3′
 AQP8fw: 5′ACACAAATACACACACTAAATTACCGGATCAATTCTAAGATAATT ATGTGTGAAC 
CAGAATTTGGTAAT 3′
AQP8rv: 5′AAATTGACTTTGAAAATACAAATTTTCTCTAGCCTTCAAGATTAATCTGG3′
 AQP9fw:
 5′ACACAAATACACACACTAAATTACCGGATCAATTCTAAGATAATTATGCAACCAGAAGGTGC 
CG 3′
AQP9rv:
5′AAATTGACTTTGAAAATACAAATTTTCCATAATTACTGACAATTCGTACTTT3′
 AQP10fw:
 5 ′ACACAAATACACACACTAAATTACCGGATCAATTC TA AG ATA AT T ATG G T T T T TAC AC A 
AGCACCTG 3′
AQP10rv:
5′AAATTGACTTTGAAAATACAAATTTTCTAACTTGCATTCCAACATTTGT3′
 AQP11fw:
 5 ′ACACAAATACACACACTAAATTACCGGATCAATTCTAAGATAAT TATGTCCCCT T TGT TG 
GGTTTG 3′
AQP11rv:
5′AAATTGACTTTGAAAATACAAATTTTCTTCCTTCTTGTTGATAGTGTGG3′
 AQP12fw:
 5 ′ACACAAATACACACACTAAATTACCGGATCAATTC TA A G ATA AT T AT G G C A G G T T T G A 
ACGTCAG3′
AQP12rv:
5′AAATTGACTTTGAAAATACAAATTTTCTGAAGAATGAGGACCTTCTAC3′
Bold sequences are the template specific part of the primers, while the sequence in italics is the Kozak 
sequence from the yeast PMR1 gene. The blue sequences are used for in vivo homologous recombination with 
the expression plasmid and the orange sequence is for recombination with the yeGFP3 PCR fragment to generate 
expression plasmids directly in the S. cerevisiae expression strain PAP1500.
The yeGFP359 PCR fragments used for making the AQP-TEV-GFP-His10 fusions were generated with the 
following primers.
GFPupTEV:
5′GAAAATTTGTATTTTCAAAGTCAATTTATGTCTAAAGGTGAAGAATTATTCACT3′
GFPrecdo:
 5′ CTTCAATGCTATCATTTCCTTTGATATTGGATCAT TCA ATGGTGATGGTGATGGTGATGGTG
ATGGTGTTTGTACAATTCATCCATACCA3′
The template specific sequences are shown in bold. The translational termination codon is in red, the ten 
histidine codons are in green, the sequence required for recombination with the AQP PCR products is shown in 
orange, while sequences required for recombination with the expression vector are shown in blue.
All PCR reactions were performed with AccuPol DNA polymerase (Amplicon, Denmark). Each AQP expres-
sion plasmid was generated by in vivo homologous recombination by transforming PAP1500 with an AQP PCR 
product plus a yeGFP3 PCR product and SalI, HindIII and BamHI digested pEMBLyex460 expression vector, 
using the transformation protocol as described61. The correct nucleotide sequences of all expression constructs 
were verified by DNA sequencing at MWG Biotech, Germany.
Small scale production of AQPs. Yeast cells were grown at 30 °C until saturation in 5 ml SD medium 
including leucine and lysine. 200 µl yeast culture was subsequently used to inoculate 5 ml SD medium supple-
mented with lysine at 30 °C until saturation. 50 ml of the same medium was inoculated with 5 ml pre-culture and 
growth continued until saturation. The 50 ml culture was used to inoculate 2 L expression medium (YP medium 
with 0.5% glucose and 3% glycerol) to OD450 = 0.05. Cells were incubated at room temperature until OD450 = 1.0 
and subsequently transferred to 15 °C. AQP production was initiated after 15 minutes by supplementation with 
200 ml 20% galactose dissolved in YP medium without glucose but with 3% glycerol.
Temperature optimization of AQP production. Yeast cells were grown at room temperature as 
described above in 2 L of expression medium. At OD450 = 1.0, half of the culture was transferred to 15 °C and 
the other half to 30 °C. After thermo-equilibration, AQP production was induced by adding 220 ml of induction 
medium (20% galactose dissolved in YP medium containing 3% glycerol and no glucose) to each flask. Samples 
were collected 0, 4, 28, 52, 76 and 100 hours post induction. Crude membranes were isolated from cells harvested 
at each time point and analyzed by measuring GFP fluorescence in 25 µg crude membranes in a spectrofluor-
ometer (Fluoroskan Ascent, Thermo Scientific) using buffer as a blank. Excitation was at 485 nm and emission 
at 520 nm. Fluorescence was converted to pmol AQP-GFP from a standard curve generated from purified GFP 
mixed with yeast membranes as previously established31,32.
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Production of Histidine tagged AQP10 in the Bioreactor. A single colony of transformed yeast 
cells was selectively propagated until saturation in 5 ml of glucose minimal medium supplemented with leucine 
and lysine. 200 µl of this culture was subsequently propagated in 5 ml of glucose minimal medium supple-
mented with lysine. The 5 ml were transferred to 50 ml of the same medium. Next day 1 l of glucose minimal 
medium supplemented with lysine was inoculated with the 50 ml pre-culture. After overnight growth the 1 l 
overnight culture was transferred to 10 liters of amino acid supplemented minimal medium with 3% glucose 
and 3% glycerol as carbon source and propagated in a 15 liters Applikon® bioreactor equipped with an ADI 
1030 Bio Controller connected to a PC running the BioExpert® software (Applikon, Holland). The initial part 
of the fermentation was performed at 20 °C. The bioreactor was fed with glucose to a final concentration of 
2% when the first amount of glucose had been metabolized. The pH of the growth medium was kept at 6.0 by 
computer-controlled addition of 1 M NH4OH. The shift from growth on glucose to growth on glycerol was 
monitored as a decrease in the rate of NH4OH consumption. At this point the bioreactor was cooled to 15 °C 
before induction of recombinant AQP production with 1 liter of 20% galactose dissolved in the initial growth 
medium lacking glucose. For time course expression experiments, 10 ml samples were taken out from the biore-
actor at various time points after galactose induction and crude membranes were prepared as described below. 
Yeast cells were harvested after 72 h.
Small scale purification of AQP-TEV-GFP-His10 fusion proteins. Yeast cells from 2 L cultures were 
harvested at 1,600 g for 10 minutes at 4 °C. Cells were lysed by glass bead homogenization in ice cold Lysis buffer 
(25 mM Imidazole 1 mM EDTA, 1 mM EGTA, 10% sucrose) containing 1 mM PMSF and 1 µg/ml of leupeptine, 
pepstatin and chymostatin as described previously30. The cell lysate was centrifuged at 4 °C at 3,000 g for 10 min-
utes and the supernatant exposed to ultracentrifugation at 40,000 rpm in a 70Ti rotor for 1.5 hours. Crude mem-
brane pellets was re-suspended in lysis buffer containing protease inhibitors and kept at −80 °C until use. Crude 
membranes were solubilized for four hours at 4 °C by slow rotation in the detergent found to be most optimal 
from the detergent screen. The solubilized protein was isolated by ultracentrifugation at 4 °C for 30 minutes at 
40,000 rpm in the 70Ti  rotor. The solubilized protein was diluted to a detergent concentration corresponding to 
1.5 times CMC of the detergent used and incubated overnight in a beaker with Ni-resin (Genscript, USA). The 
beaker content was transferred to a 2 ml CellThru disposable column (Clontech, USA). After collection of the run 
through, the column was washed with Buffer containing 10 mM, 30 mM, 100 mM, 250 mM or 500 mM imidazole. 
All buffers contained detergent at a concentration corresponding to 1.5 times CMC. Fluorescence in each frac-
tion was quantified using a spectrofluorometer (Fluoroskan Ascent, Thermo Scientific) using buffer as a blank. 
Excitation was at 485 nm and emission at 520 nm.
Large-scale purification of Histidine tagged AQP10. For large-scale protein purification crude yeast 
membranes were isolated as for small-scale cultures, re-suspended in ice-cold solubilization buffer (20 mM Tris 
pH 7.5, 200 mM NaCl, 20% glycerol, 5 mM β-ME, 1 mM PMSF) supplemented with SIGMAFAST protease inhib-
itor cocktail (Sigma, USA) and solubilized for 4 h in the presence of 2% (w/v) n-decyl-β-D-maltopyranoside (DM; 
Anatrace). Solubilised material was clarified by 1-h centrifugation at 120,000 × g, diluted 2 × in immobilized 
metal affinity chromatography (IMAC) buffer (20 mM Tris pH 7.5, 200 mM NaCl, 20% glycerol, 5 mM β-ME and 
0.2 (w/v)% DM) supplemented with 50 mM imidazole and filtered through a 0.45 μm filter. The sample was sub-
sequently loaded onto a 5 mL Ni-NTA HisTrap HP column (GE Healthcare, USA), washed intensively in elution 
buffer (20 mM Tris pH 7.5, 200 mM NaCl, 20% glycerol, 5 mM β-ME and 1 (w/v)% n-octyl-β-D-glucopyranoside 
(bOG; Anatrace)) and eluted using a linear imidazole gradient (50–500 mM). Protein yields were quantified by 
ultraviolet–visible spectroscopy at A280 (ɛAQP10His10 = 40910 M−1 cm−1). Top fractions were pooled, concen-
trated to 1 mL using 100 kDa cut-off centrifugal concentrator (Sartorius) and loaded onto a size exclusion chro-
matography (SEC) Superdex increase 200 10/300 GL column (GE Healthcare) equilibrated in SEC buffer (20 mM 
Tris pH 7.5, 100 mM NaCl, 10% glycerol, 2 mM β-ME and 1% bOG). Purity of all samples collected during pro-
tein purification was analysed using SDS–PAGE.
Live cell bioimaging. Localization of heterologously expressed GFP-tagged AQPs was determined by visu-
alizing GFP fluorescence in whole cells at 1,000 × magnification, using a Nikon Eclipse E600 microscope coupled 
to an Optronics Magnafire model S99802 camera.
Removal of N-glycosylation. Crude membranes containing 200 fluorescence units were incubated with 
500 units of Endo-H (New Biolabs, USA) at 4 °C in Lysis buffer overnight alongside a negative control lacking 
addition of Endo-H. Samples were separated in 12% SDS-PAGE gels and visualized by in-gel fluorescence using 
a LAS 4000 Imager (GE Healthcare, USA).
Detergent screens. Crude membranes were incubated in buffer B (25 mM Tris-HCl, 10 mM Imidazole, 
0.5 M NaCl, 10% glycerol, pH 7.6) supplemented with protease inhibitors (1 mM PMSF and 1 μg/ml Leupeptin, 
Chymostatin and Pepstatin, respectively) at protein:detergent:CHS ratios (w/w) of 1:1:0.3; 1:2:0.6 or 1:3:1.0. The 
screen included the following detergents FC-12, n-dodecylphosphocholine; FC-13, n-Tridecylphosphocholine; 
FC-14, n-Tetradecylphosphocholine; FC-16, n-Hexadecylphosphocholine; LDAO, Lauryldimethylamine 
N-oxide; Cymal-5, 5-cyclohexyl-1-pentyl-β-D-maltoside; DDM, n-dodecyl-β-D-maltopyranoside;DM, 
n-decyl-β-Dmaltopyranoside; Detergents were either of Anagrade quality and purchased from Affymetrix, 
UK or from Glycon, Germany. Solubilization was performed at slow rotation at 4 °C for 1 hour. Solubilized 
AQP-TEV-GFP-His10 protein was separated from un-solubilized cell debris by ultra-centrifugation at 70,000 rpm 
for 30 minutes at 4 °C in a Beckman Optima™TLX ultracentrifuge fitted with an S.N. 96U 826 rotor. Fluorescence 
was detected in microplates in a spectrofluorometer (Fluoroskan Ascent, Thermo Scientific) using buffer as a 
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blank. Excitation was at 485 nm and emission at 520 nm. Solubilization efficiency was estimated as fluorescence 
in the supernatant divided by fluorescence in the crude membranes used for solubilization.
Fluorescence-detection size exclusion chromatography. Solubilized crude membranes were ana-
lyzed by fluorescence-detection size exclusion chromatography (FSEC) on a Superose 6 Increase 200 10/300 
GL column attached to an ÄKTA Purifier (GE Healthcare, USA), using FSEC buffer (20 mM TRIS-HCl, 0.15 M 
NaCl, 0.03% DDM). The effluent from the column was coupled to a fluorescence detector (Shimadzu Prominence 
RF-20A) to measure fluorescence and visualize the elution profile of the GFP tagged AQPs. To estimate the 
molecular weight of the solubilized AQP-TEV-GFPHis10 proteins, we used the HMW calibration kit from GE 
Healthcare dissolved at 20 mg/ml in FSEC buffer. The molecular masses were: Ovalbumin 43 kDa; Conalbumin 
75 kDa; Aldolase 158 kDa; Ferritin 440 kDa; Thyroglobulin 669 kDA; Blue Dextran 2000 kDa. The elution volume 
for Blue Dextran defined the void volume.
Ni-affinity purification. For purification the AQP-TEV-GFP-His10 fusions were solubilized in buffer B at 
slow rotation at 4 °C for 1 hour using the protein:detergent:CHS ratio (w/w/w) that gave the most monodisperse 
FSEC profile. Non-solubilized material was pelleted at 70,000 rpm in the Beckmann Optima TL200 ultracentri-
fuge for 30 minutes at 4 °C. Solubilized membranes were diluted in buffer B with protease inhibitors to a detergent 
concentration corresponding to 1.5 times CMC and incubated overnight in a glass beaker with 1 ml of Ni-NTA 
Agarose (Genscript, Germany) at 4 °C with slow magnetic stirring. The Agarose slurry was subsequently loaded 
onto a 2 ml CellThru disposable column (Clontech, USA). After collection of the run through, the column was 
washed with Buffer B containing 10 mM, 30 mM, 100 mM, 250 mM or 500 mM imidazole. All buffers contained 
detergent corresponding to 1.5 times CMC.
Fluorescence in each fraction was quantified using a spectrofluorometer (Fluoroskan Ascent, Thermo 
Scientific) using buffer as a blank. Excitation was at 485 nm and emission at 520 nm.
TEV cleavage. Purified AQP-TEV-GFP-His10 fusion proteins were digested O/N in snakeskin dialysis bags 
(Thermo Scientific, USA) with dialysis buffer (20 mM phosphate pH 7.0, 200 mM NaCl, 1.5 x CMC detergent) 
and TEV protease33 at room temperature with a protein to TEV ratio of 1:10 (w/w). Digestion efficiency was esti-
mated by in-gel fluorescence.
Protein quantification. Protein concentrations in crude membranes were determined by the BCA assay62 
according to the Manufacturer’s specifications (Sigma, USA) using chicken ovalbumin as a standard.
SDS-PAGE and western blotting. SDS-PAGE separation of proteins, in-gel fluorescence and west-
ern blotting were done as previously described31–33. A mixture of two polyclonal anti-GFP-antibodies custom 
generated at Pineda, Germany, was used for AQP-TEV-GFP-His10 fusion proteins detection in western blots 
in conjunction with a horse radish conjugated anti-rabbit secondary antibody. Horse radish peroxidase conju-
gated Concanavalin-A (SigmaAldrich L6397) was used to identify glycosylated proteins after western blotting. 
Chemiluminescence detection was performed using the Immobilon Western Chemiluminescent HRP Substrate 
from Millipore® and the LAS4000 imager (GE Healthcare, USA).
Proteopolymersome preparation and characterization. Poly(2-methyloxazoline)-block- 
poly(dimethylsiloxane) diblock co-polymer PDMS34PMOXA11 (PDMS-PMOXA) was purchased from DSM (Het 
Overloon 1, 6411 TE Heerlen, the Netherlands) and was used as received.
PDMS34PMOXA11 polymersomes and proteopolymersomes were prepared by the co-solvent method as 
described63. In short, 15 mg PDMS-PMOXA copolymer were dissolved in 50 µl ethanol, which was then added 
dropwise to 4450 µl Phosphate buffered saline (PBS, 10 mM, pH 7.2), followed by dialysis against PBS buffer for 
24 hours with three buffer exchanges. For proteopolymersomes each AQP was incorporated by addition of deter-
gent solubilized AQPs with a concentration of 25 µg before dialysis. Following dialysis all solutions were extruded 
15 times through a 200 nm polycarbonate filter using an Avestin Extruder.
The size of extruded polymersomes and proteopolymersomes (hydrodynamic diameter) were determined by 
dynamic light scattering using ZetaSizer NanoZs (Malvern) with measuring temperature of 20 °C.
The water permeability of reconstituted AQPs were measured using a Bio-Logic SFM 300 stopped-flow device 
(Bio-Logic Science Instruments, France), with a monochromator at 517 nm and a cut off filter at 530 nm. For 
each stopped-flow test, 0.13 ml polymersome solution or proteopolymersome solution was mixed rapidly with 
0.13 ml NaCl solution (0.5 M). Resulting proteopolymersome volume change rate measured by light scattering 
was recorded as a function of time with a deadtime of 5 ms. Thus, the effective extravesicular concentration is 
0.25 M plus the sodium present in the 10 mM PBS resulting in a final NaCl concentration of 0.387 M. NaCl as 
an osmolyte provides a good signal to noise ratio and previous studies have shown that the optimal concentra-
tion of osmolyte is 0.3–0.6 M NaCl44. This condition allows for fitting the stopped flow signal to more than 95% 
accuracy44.
Proteopolymersome volume reduction was due to water transport outward as an effect of the change in osmo-
larity and the water permeability of the proteopolymersome. The results are reported as an average of 10 meas-
urements. The average rate constant ki of the stopped flow signal was determined by fitting of the normalized light 
scattering curves to a double order exponential function where the initial rate constant is directly proportional to 
the water flux though the proteopolymersome.
In order to test the glycerol flux through AQP channels, 3 ml extruded polymersomes (polymeric vesicles) 
were incubated with 3 ml 2 M glycerol overnight at 4 °C to equilibrate the glycerol concentration across the pol-
ymeric vesicles. After incubation, the dimensions of the polymeric vesicles were determined by dynamic light 
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scattering. Polymeric vesicles only swell if the tested AQP can mediate a glycerol flux otherwise it will shrink due 
to the outward osmotic gradient. The water flux trough AQP channels after incubation was tested in a similar 
way using the stopped-flow method, by mixing with 0.5 M NaCl that exhibits the same osmotic pressure as 1 M 
glycerol concentration, incubating with the polymer vesicles. For AQPs that only transport water the ki with or 
without prior glycerol incubation will be identical when exposed to NaCl, while the ki for the Aquaglyceroporins 
will decrease after glycerol incubation. The Δki (ki without glycerol equilibration– ki after glycerol equilibration) 
will then be zero for an orthodox AQP but larger than one for an aquaglyceroporin.
The water flux trough AQP channels after incubation was tested in a similar way using the stopped-flow 
method, by mixing with 0.5 M NaCl that exhibits the same osmotic pressure as 1 M glycerol concentration64–66.
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